Mabwell passes Brazilian GMP inspection for denosumab
Mabwell dual listed under 688062 SH and 02493 HK announced its subsidiary T mab passed the Brazilian Health Regulatory Agency s GMP inspection for its denosumab injections marking a second PIC S GMP certification
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.